© 1994 by Oxford University Press
Journal of the National Cancer Institute, Vol. 86, No. 4, 281-286,
February 16, 1994
© 1994 Oxford University Press
Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer
*Correspondence to: Peter H. Gann, M.D., Department of Preventive Medicine, North western University School of Medicine, 680 N Lake Shore Dr., Suite 1102, Chicago, IL 60611
BACKGROUND:: Although some evidence suggests that dietary fat intake is related to prostate cancer, epidemiologic studies have been inconsistent.
PURPOSE:: Our purpose was to assess the association between plasma lipid levels, particularly linoleic and 
-linolenic acids, and the development of prostate cancer.
METHODS:: In 1982, at the start of the Physicians' Health Study, 14916 U.S. male physicians provided plasma samples, which were frozen at -82 °C. Data accumulated from a series of question aires were used to assess the intake of various foods. We used a nested case-control design to compare the fatty acid compositions in plasma from 120 men who later developed prostate cancer with 120 matched controls who did not. Individual fatty acids were measured in plasma as a percentage of total fatty acids, using capillary gas chromatography. Conditional logistic regression models were used to obtain odds ratio estimates while adjusting simultaneously for the effects of one or more potential confounders. Results: The relative risks (RRs) of prostate cancer for men in successively higher quartiles of plasma -linolenic acid level were 3.0 (95% confidence interval (CI) = 1.2–7.3), 3.4 (95% CI = 1.6–7.5), and 2.1 (95% CI = 0.9–4.9), compared with those with levels below the detection threshold (P trend =.03). For linoleic acid, RRs in successively higher quartiles were 0.7 (95% CI = 0.4–1.5), 0.8 (95% CI = 0.4–1.6), and 0.6 (95% CI = 0.3–1.3), with the lowest quartile as referent (P trend =.24). The effect estimates were not notably altered by adjustment for exercise, body mass, meat and dairy consumption, or other fatty acid levels in the plasma. The RR for eating red meat at least five times per week compared with less than once a week was 2.5 (95% CI =0.9–6.7) and was little changed by adjustment for -linolenic acid, although -linolenic acid levels were correlated with intake of red meat and butter. The association of -linolenic acid levels with prostate cancer was greater among men with low linoleic acid and reduced meat intake.
CONCLUSIONS:: These results suggest that low plasma levels of -linolenic acid might be associated with reduced risk of prostate cancer, independently of high meat intake. High linoleic acid and low marine fatty oils were not associated with increased risk, as previously hypothesized.
IMPLICATIONS:: The effects of dietary -linolenic acid, particularly from vegetable sources, warrant further study. The effects of dietary linoleic acid and marine fatty acids seen in animal bioassays might not apply to human prostate cancer. [J Natl Cancer Inst 86: 281–286, 1994]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A Simon, Y.-H. Chen, and S. Bent The relation of {alpha}-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1558S - 1564S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Chavarro, M. J Stampfer, M. N Hall, H. D Sesso, and J. Ma A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1297 - 1303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. L Crowe, N. E Allen, P. N Appleby, K. Overvad, I. V Aardestrup, N. F Johnsen, A. Tjonneland, J. Linseisen, R. Kaaks, H. Boeing, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition Am. J. Clinical Nutrition, November 1, 2008; 88(5): 1353 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Jones, W.-L. Liu, A. B. Araujo, S. V. Kasl, S. N. Silvera, H. Soler-Vila, M. G.M. Curnen, and R. Dubrow Explaining the Race Difference in Prostate Cancer Stage at Diagnosis Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2825 - 2834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Jayachandran and S. J. Freedland Prevention of Prostate Cancer: What We Know and Where We Are Going American Journal of Men's Health, June 1, 2008; 2(2): 178 - 189. [Abstract] [PDF]
|
|
|
|
|
|
F. L Crowe, T. J Key, P. N Appleby, R. C Travis, K. Overvad, M. U Jakobsen, N. F Johnsen, A. Tjonneland, J. Linseisen, S. Rohrmann, et al. Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1405 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort Carcinogenesis, May 1, 2008; 29(5): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koutros, A. J. Cross, D. P. Sandler, J. A. Hoppin, X. Ma, T. Zheng, M. C.R. Alavanja, and R. Sinha Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 80 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Chavarro, M. J. Stampfer, H. Li, H. Campos, T. Kurth, and J. Ma A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rip, M. C. Nierman, C. J. Ross, J. W. Jukema, M. R. Hayden, J. J.P. Kastelein, E. S.G. Stroes, and J. A. Kuivenhoven Lipoprotein Lipase S447X: A Naturally Occurring Gain-of-Function Mutation Arterioscler Thromb Vasc Biol, June 1, 2006; 26(6): 1236 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodriguez, M. L. McCullough, A. M. Mondul, E. J. Jacobs, A. Chao, A. V. Patel, M. J. Thun, and E. E. Calle Meat Consumption among Black and White Men and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 211 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Cross, U. Peters, V. A. Kirsh, G. L. Andriole, D. Reding, R. B. Hayes, and R. Sinha A Prospective Study of Meat and Meat Mutagens and Prostate Cancer Risk Cancer Res., December 15, 2005; 65(24): 11779 - 11784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Chan, P. H. Gann, and E. L. Giovannucci Role of Diet in Prostate Cancer Development and Progression J. Clin. Oncol., November 10, 2005; 23(32): 8152 - 8160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Anttila, L. Tenkanen, S. Lumme, M. Leinonen, R. E. Gislefoss, G. Hallmans, S. Thoresen, T. Hakulinen, T. Luostarinen, P. Stattin, et al. Chlamydial Antibodies and Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Terry, J. B. Terry, and T. E. Rohan Long-Chain (n-3) Fatty Acid Intake and Risk of Cancers of the Breast and the Prostate: Recent Epidemiological Studies, Biological Mechanisms, and Directions for Future Research J. Nutr., December 1, 2004; 134(12): 3412S - 3420S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Nelson Prostate Cancer Prevention J. Nutr., November 1, 2004; 134(11): 3211S - 3212S. [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Dennis, L. G. Snetselaar, B. J. Smith, R. E. Stewart, and M. E. C. Robbins Problems with the Assessment of Dietary Fat in Prostate Cancer Studies Am. J. Epidemiol., September 1, 2004; 160(5): 436 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F Leitzmann, M. J Stampfer, D. S Michaud, K. Augustsson, G. C Colditz, W. C Willett, and E. L Giovannucci Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer Am. J. Clinical Nutrition, July 1, 2004; 80(1): 204 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Homma, Y. Kondo, M. Kaneko, T. Kitamura, W. T. Nyou, M. Yanagisawa, Y. Yamamoto, and T. Kakizoe Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate Carcinogenesis, June 1, 2004; 25(6): 1011 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Brouwer, M. B. Katan, and P. L. Zock Dietary {alpha}-Linolenic Acid Is Associated with Reduced Risk of Fatal Coronary Heart Disease, but Increased Prostate Cancer Risk: A Meta-Analysis J. Nutr., April 1, 2004; 134(4): 919 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mannisto, P. Pietinen, M. J. Virtanen, I. Salminen, D. Albanes, E. Giovannucci, and J. Virtamo Fatty Acids and Risk of Prostate Cancer in a Nested Case-Control Study in Male Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1422 - 1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Godley, A. P. Schenck, M. A. Amamoo, V. J. Schoenbach, S. Peacock, M. Manning, M. Symons, and J. A. Talcott Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer J Natl Cancer Inst, November 19, 2003; 95(22): 1702 - 1710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]
|
|
|
|
|
|
G. L. Firestone and L. F. Bjeldanes Indole-3-Carbinol and 3-3'-Diindolylmethane Antiproliferative Signaling Pathways Control Cell-Cycle Gene Transcription in Human Breast Cancer Cells by Regulating Promoter-Sp1 Transcription Factor Interactions J. Nutr., July 1, 2003; 133(7): 2448S - 2455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wilkinson and G. W. Chodak Critical Review of Complementary Therapies for Prostate Cancer J. Clin. Oncol., June 1, 2003; 21(11): 2199 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Block Integrative Physician's Perspective Integr Cancer Ther, March 1, 2003; 2(1): 85 - 90. [PDF]
|
|
|
|
|
|
P. D Terry, T. E Rohan, and A. Wolk Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence Am. J. Clinical Nutrition, March 1, 2003; 77(3): 532 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. van Gils, R. M. Bostick, M. C. Stern, and J. A. Taylor Differences in Base Excision Repair Capacity May Modulate the Effect of Dietary Antioxidant Intake on Prostate Cancer Risk: An Example of Polymorphisms in the XRCC1 Gene Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1279 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gugliucci, L. Ranzato, L. Scorrano, R. Colonna, V. Petronilli, C. Cusan, M. Prato, M. Mancini, F. Pagano, and P. Bernardi Mitochondria Are Direct Targets of the Lipoxygenase Inhibitor MK886. A STRATEGY FOR CELL KILLING BY COMBINED TREATMENT WITH MK886 AND CYCLOOXYGENASE INHIBITORS J. Biol. Chem., August 23, 2002; 277(35): 31789 - 31795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kristal, J. H. Cohen, P. Qu, and J. L. Stanford Associations of Energy, Fat, Calcium, and Vitamin D with Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., August 1, 2002; 11(8): 719 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tang, B. Bhatia, C. J. Maldonado, P. Yang, R. A. Newman, J. Liu, D. Chandra, J. Traag, R. D. Klein, S. M. Fischer, et al. Evidence That Arachidonate 15-Lipoxygenase 2 Is a Negative Cell Cycle Regulator in Normal Prostate Epithelial Cells J. Biol. Chem., May 3, 2002; 277(18): 16189 - 16201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. P. Kelavkar, J. B. Nixon, C. Cohen, D. Dillehay, T. E. Eling, and K. F. Badr Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis Carcinogenesis, November 1, 2001; 22(11): 1765 - 1773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Chung, S. H. Mitchell, J.-S. Zhang, and C. Y. F. Young Effects of docosahexaenoic acid and eicosapentaenoic acid on androgen-mediated cell growth and gene expression in LNCaP prostate cancer cells Carcinogenesis, August 1, 2001; 22(8): 1201 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aline Charles, A. Fontbonne, N. Thibult, J.-R. Claude, J.-M. Warnet, G. Rosselin, P. Ducimetiere, and E. Eschwege High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study Am. J. Epidemiol., February 1, 2001; 153(3): 292 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Hsing, J. Deng, I. A. Sesterhenn, F. K. Mostofi, F. Z. Stanczyk, J. Benichou, T. Xie, and Y.-T. Gao Body Size and Prostate Cancer: A Population-based Case-Control Study in China Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1335 - 1341. [Abstract] [Full Text]
|
|
|
|
|
|
Eduardo De Stéfani, H. Deneo-Pellegrini, P. Boffetta, A. Ronco, and M. Mendilaharsu {{alpha}}-Linolenic Acid and Risk of Prostate Cancer: A Case-Control Study in Uruguay Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 335 - 338. [Abstract] [Full Text]
|
|
|
|
|
|
L. N. Kolonel, A. M. Y. Nomura, and R. V. Cooney Dietary Fat and Prostate Cancer: Current Status J Natl Cancer Inst, March 3, 1999; 91(5): 414 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Hayes, R. G. Ziegler, G. Gridley, C. Swanson, R. S. Greenberg, G. M. Swanson, J. B. Schoenberg, D. T. Silverman, L. M. Brown, L. M. Pottern, et al. Dietary Factors and Risks for Prostate Cancer among Blacks and Whites in the United States Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 25 - 34. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Ghosh and C. E. Myers Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells PNAS, October 27, 1998; 95(22): 13182 - 13187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lopez-Otin and E. P. Diamandis Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features Endocr. Rev., August 1, 1998; 19(4): 365 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Clinton, A. L. Mulloy, S. P. Li, H. J. Mangian, and W. J. Visek Dietary Fat and Protein Intake Differ in Modulation of Prostate Tumor Growth, Prolactin Secretion and Metabolism, and Prostate Gland Prolactin Binding Capacity in Rats J. Nutr., February 1, 1997; 127(2): 225 - 237. [Abstract] [Full Text]
|
|